Works matching Nilsson-Ehle, Herman


Results: 32
    1
    2

    Quality of life, physical function and MRI T2* in elderly low-risk MDS patients treated to a haemoglobin level of ≥120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusions.

    Published in:
    European Journal of Haematology, 2011, v. 87, n. 3, p. 244, doi. 10.1111/j.1600-0609.2011.01654.x
    By:
    • Nilsson-Ehle, Herman;
    • Birgegård, Gunnar;
    • Samuelsson, Jan;
    • Antunovic, Petar;
    • Astermark, Jan;
    • Garelius, Hege;
    • Engström, Lena M.;
    • Kjeldsen, Lars;
    • Nilsson, Lars;
    • Olsson, Anna;
    • Skov-Holm, Mette;
    • Wallvik, Jonas;
    • Gulbrandsen, Nina;
    • Hellström-Lindberg, Eva
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Error in a study of the outcome of mantle cell lymphoma: Nordic MCL2 Trial Update: 6-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur

    Published in:
    British Journal of Haematology, 2012, v. 158, n. 6, p. 815, doi. 10.1111/bjh.12006
    By:
    • Geisler, Christian H.;
    • Kolstad, Arne;
    • Laurell, Anna;
    • Jerkeman, Mats;
    • Räty, Riikka;
    • Andersen, Niels S.;
    • Pedersen, Lone B.;
    • Eriksson, Mikael;
    • Nordström, Marie;
    • Kimby, Eva;
    • Bentzen, Hans;
    • Kuittinen, Outi;
    • Lauritzsen, Grete F.;
    • Nilsson-Ehle, Herman;
    • Ralfkiær, Elisabeth;
    • Ehinger, Mats;
    • Sundström, Christer;
    • Delabie, Jan;
    • Karjalainen-Lindsberg, Marja-Liisa;
    • Brown, Peter
    Publication type:
    Article
    18

    Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur.

    Published in:
    British Journal of Haematology, 2012, v. 158, n. 3, p. 355, doi. 10.1111/j.1365-2141.2012.09174.x
    By:
    • Geisler, Christian H.;
    • Kolstad, Arne;
    • Laurell, Anna;
    • Jerkeman, Mats;
    • Räty, Riikka;
    • Andersen, Niels S.;
    • Pedersen, Lone B.;
    • Eriksson, Mikael;
    • Nordström, Marie;
    • Kimby, Eva;
    • Bentzen, Hans;
    • Kuittinen, Outi;
    • Lauritzsen, Grete F.;
    • Nilsson-Ehle, Herman;
    • Ralfkiær, Elisabeth;
    • Ehinger, Mats;
    • Sundström, Christer;
    • Delabie, Jan;
    • Karjalainen-Lindsberg, Marja-Liisa;
    • Brown, Peter
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27

    15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial ( MCL2): prolonged remissions without survival plateau.

    Published in:
    British Journal of Haematology, 2016, v. 175, n. 3, p. 410, doi. 10.1111/bjh.14241
    By:
    • Eskelund, Christian W.;
    • Kolstad, Arne;
    • Jerkeman, Mats;
    • Räty, Riikka;
    • Laurell, Anna;
    • Eloranta, Sandra;
    • Smedby, Karin E.;
    • Husby, Simon;
    • Pedersen, Lone B.;
    • Andersen, Niels S.;
    • Eriksson, Mikael;
    • Kimby, Eva;
    • Bentzen, Hans;
    • Kuittinen, Outi;
    • Lauritzsen, Grete F.;
    • Nilsson‐Ehle, Herman;
    • Ralfkiær, Elisabeth;
    • Ehinger, Mats;
    • Sundström, Christer;
    • Delabie, Jan
    Publication type:
    Article
    28
    29
    30
    31
    32